Product Images Rizatriptan Benzoate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Rizatriptan Benzoate NDC 51407-679 by Golden State Medical Supply, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 2 provides an estimated probability of patients taking a second dose of Rizatriptan Benzoate Tablets or other medication for migraines over a 24-hour period following the initial dose of study treatment. This data was obtained from pooled Studies 1, 2, 3, and 4. The Kaplan-Meier plot shows the percentage of patients who took the second dose at different time points post-dose. Patients who did not use additional treatments were censored at 24 hours. The plot includes patients who had a headache response at 2 hours and those who did not respond to the initial dose. Remedication within 2 hours post-dose was not allowed.*
This is a figure titled "Observed Percentage of Patients Reporting No Headache Pain by 2 Hours Post-Dose in Study 7". It shows the percentage of patients reporting no headache pain after taking Rizatriptan Benzoate 0D Tablets compared to a placebo. The graph displays percentages from 0% to 100%, with time intervals marked on the x-axis.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.